Addex Therapeutics is a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders.

Products, services, technology
  • Dipraglurant for post-stroke sensorimotor recovery
  • ADX71149 (mGlu2 Pam) - indication under evalutation
  • GABAB PAM for substance use disorder
  • GABAB PAM for chronic cough
Location
Additional address info
  • Campus Biotech Building - 5th floor
Canton
Facts & figures
  • Type of organization
    Public company
  • Year of foundation
    2002
  • Number of employees in Switzerland
    1-9
Key business

You may also be interested in